WP
QTTB icon

Woodline Partners’s Q32 Bio QTTB Stock Holding History

Woodline Partners’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.65M Buy
+286,212
New +$2.39M 0.01% 755
2024
Q4 		– Sell
-106,901
Closed -$4.77M – 1015
2024
Q3 		$4.77M Buy
+106,901
New +$3.93M 0.04% 392
2024
Q2 		– Sell
-15,584
Closed -$266K – 699
2024
Q1 		$266K Buy
+15,584
New +$215K ﹤0.01% 505
2022
Q1 		– Sell
-53,726
Closed -$3.52M – 836
2021
Q4 		$3.52M Buy
+53,726
New +$5.21M 0.05% 331

Other funds holding QTTB

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.89B AUM 55.94% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Woodline Partners's QTTB Position: Q2 2026 in Review

Woodline Partners opened a new position in Q32 Bio (QTTB) in Q2 2026: 286,212 shares worth $3.65M. The stake represents 0.01% of the portfolio and ranks #755 among its holdings. This is a return to the name: Woodline Partners previously reported a position in QTTB as recently as Q3 2024.

Woodline Partners first reported a position in QTTB in Q4 2021 and has held it in 4 quarters since. The position peaked at $4.77M in Q3 2024. 72 funds tracked by Wall St. Rank hold QTTB as of Q2 2026.

  • Woodline Partners held 286,212 shares of Q32 Bio worth $3.65M as of Q2 2026.
  • Q32 Bio was a new Woodline Partners position in Q2 2026.
  • Q32 Bio made up 0.01% of Woodline Partners's portfolio in Q2 2026, its #755 holding.
  • Woodline Partners first reported a position in Q32 Bio in Q4 2021 and has held it in 4 quarters since.
  • Woodline Partners's Q32 Bio position peaked at $4.77M in Q3 2024.
  • 72 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.